Cyclophosphamide-associated bladder cancers and considerations for survivorship care: A systematic review.

MLA

Chou, Wesley H., et al. “Cyclophosphamide-Associated Bladder Cancers and Considerations for Survivorship Care: A Systematic Review.” Urologic Oncology, vol. 39, no. 10, Oct. 2021, pp. 678–85. EBSCOhost, https://doi.org/10.1016/j.urolonc.2021.05.017.

APA

Chou, W. H., McGregor, B., Schmidt, A., Carvalho, F. L. F., Hirsch, M. S., Chang, S. L., Kibel, A., & Mossanen, M. (2021). Cyclophosphamide-associated bladder cancers and considerations for survivorship care: A systematic review. Urologic Oncology, 39(10), 678–685. https://doi.org/10.1016/j.urolonc.2021.05.017

Chicago

Chou, Wesley H, Bradley McGregor, Andrew Schmidt, Filipe L F Carvalho, Michelle S Hirsch, Steven L Chang, Adam Kibel, and Matthew Mossanen. 2021. “Cyclophosphamide-Associated Bladder Cancers and Considerations for Survivorship Care: A Systematic Review.” Urologic Oncology 39 (10): 678–85. doi:10.1016/j.urolonc.2021.05.017.